Ad is loading...
JOEAX
Price
$11.53
Change
-$0.01 (-0.09%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

JOEAX vs RNWFX

Header iconJOEAX vs RNWFX Comparison
Open Charts JOEAX vs RNWFXBanner chart's image
JOHCM Emerging Markets Opps Investor
Price$11.53
Change-$0.01 (-0.09%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
JOEAX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JOEAX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JOEAX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. JOEAX (1.09B). RNWFX (1.51) and JOEAX (1.49) have matching dividends . JOEAX was incepted earlier than RNWFX: JOEAX (11 years) vs RNWFX (23 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. JOEAX (29.34). JOEAX has a lower initial minimum investment than RNWFX: JOEAX (0) vs RNWFX (250). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. JOEAX (10.96). JOEAX return over 5 years is better than : 19.05 vs. RNWFX (17.17).
JOEAXRNWFXJOEAX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD6.4647.09991%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B60.9B2%
Annual Yield % from dividends1.491.5199%
Returns for 1 year10.9611.5495%
Returns for 3 years-5.07-14.5535%
Returns for 5 years19.0517.17111%
Returns for 10 years21.9941.0054%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics